Clin2
NCT07689656Possibly a fitRecruiting

PET imaging study for prostate cancer using a new tracer

Prostate Cancer

Part of Cancer, Kidney & urinary clinical trials.

This trial tests a new radioactive tracer called ELI421 to see how well it works for PET imaging in people with prostate cancer. It may help doctors find cancer more clearly.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
50 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have been diagnosed with prostate cancer through a biopsy or other lab test.
  • Your doctor says you need a PSMA PET scan.
  • You are in generally good health, able to do daily activities without major problems.
  • You agree to use effective birth control for 6 months after the study drug if you or your partner could become pregnant.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07830212Not yet recruiting· Phase 2
Pet imaging for prostate cancer detection

This study tests a new imaging method (PET scan) that uses a special tracer to find prostate cancer cells, whether it's the first diagnosis or a recurrence after treatment. The goal is to see how well this imaging works for locating cancer in the body.

Wuhan, Hubei
NCT06696326Recruiting
New PET scan for prostate cancer detection

This study tests a new type of PET/CT scan that uses a special tracer (68Ga-MY6349) to better see prostate cancer in the body. It may help doctors find cancer that has come back or spread, so you can get the right treatment sooner.

Xiamen, Fujian
NCT07600554Recruiting· Phase 1
Imaging Study for Prostate Cancer Detection

This research study tests a new imaging scan (called 68Ga-OncoACP3-PET/CT) to help find prostate cancer and see where it may have spread. The scan uses a radioactive tracer to help doctors visualize cancer cells and decide on the best treatment options.

Bergamo, Bergamo
NCT07365397Not yet recruiting
Comparing two PSMA PET scans for advanced prostate cancer

This study looks at how well two different PSMA PET scans work for men with advanced prostate cancer. The scans help doctors see where the cancer is, which can guide treatment decisions and help you and your doctor plan next steps.

NCT05582876Recruiting
PET/MR scan to plan personalized prostate cancer treatment

This study uses a special scan called PET/MR with a prostate-focused tracer to help doctors choose the best next treatment for prostate cancer. It may be most helpful if you are planning major treatment or if your cancer has come back after prior treatment.

Bialystok
NCT07639801Not yet recruiting
New PET scan for diagnosing solid tumors

This study is testing a new type of PET scan that uses a special tracer to make tumors easier to see. It may help doctors get more accurate information about your tumor before you have a biopsy or surgery.

Hear when a new Prostate cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.